Reinforcement-enhancing effects of NRT
Reinforcement-enhancing effects of NRT
批准号:
8754436
负责人:
KENNETH Alan PERKINS
金额:
$26.95万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-15 至 2017-06-30
关键词:
AbstinenceAccountingAcuteAddressAffectAnimal ModelAreaAttenuatedAuditoryBupropionCigaretteClinicalCuesDependenceDrug KineticsEnvironmentFutureHumanIntakeKineticsMusicNegative ReinforcementsNeurobiologyNicotineNicotine DependenceNoiseNoseOutcomePharmaceutical PreparationsPlacebosPredictive ValuePsychological reinforcementRelapseReplacement TherapyResearchRewardsRodentSelf-AdministeredSensorySmokerSmokingSpecificityStimulusTestingTherapeuticTimeTobacco smokingVisualWithdrawalcigarette smokingclinical applicationclinically relevantdesigndrug of abusenicotine patchnicotine replacementpre-clinicalpre-clinical researchpreventpublic health relevancereinforcersmoking cessationsuccesstreatment responsevarenicline
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): "Reinforcement enhancing effects of NRT" Nicotine clearly has primary and secondary reinforcing effects, as nicotine is self-administered and stimuli associated with nicotine ("cues") can become conditioned reinforcers of responding. Overlooked until recently is non-human research showing that nicotine has a third reinforcing function, that of reinforcement enhancing effects, or increasing reinforcing efficacy of rewards unrelated to nicotine intake. Notably, we recently demonstrated reinforcement enhancing effects, perhaps for the first time in humans, of nicotine intake via tobacco smoking, supporting clinical applicability of these preclinical research findings. Similar effects in both nondependent
and dependent smokers and other findings indicated dependence and withdrawal as not necessary for these nicotine effects to occur. Yet, these effects may be specific to only some types of reinforcers, especially positive sensory rewards (visual, auditory, etc.). Also, nicotine' kinetics do not influence its reinforcement enhancing effects in animal models, in contrast to its primary and secondary effects, but reinforcement enhancing effects of rapid versus gradual intake of nicotine per se warrants confirmation in humans. Nicotine via means other than smoking, such as nicotine replacement therapy (NRT), can assess effects of nicotine per se on enhancing reinforcement and determine its clinical predictive value in quitting smokers. NRT also can test if pharmacokinetics influences this reinforcement enhancing effect, via rapid (nasal spray) vs. gradual (patch) nicotine intake. Study 1 will examine influences of nicotine per se (versus placebo) on responding for reinforcers in 60 nondependent and dependent smokers to confirm our results with nicotine via smoking, using our well-validated within-subjects design to increase power. We hypothesize that responding will be greater after NRT (patch or spray) versus placebo, indicating reinforcement enhancing effects of nicotine per se, and we will explore whether these effects differ by type of reward, showing specificity. Study 2 will determine if greater reinforced responding due to NRT early in abstinence predicts days to relapse with NRT in 60 treatment-seeking smokers making a permanent quit attempt. We hypothesize that a greater increase in reinforced responding due to NRT early in cessation will predict longer duration of abstinence. This research is highly significant because demonstrating reinforcement enhancing effects of nicotine per se in humans would have important implications for understanding: an overlooked reinforcing effect of nicotine that may help account for persistence of dependence, some of the efficacy of NRT for aiding smoking cessation, and perhaps potentially similar actions of other therapeutic medications or other drugs of abuse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
-
批准号:10452567
-
项目类别:
-
资助金额:$210.73万
-
财政年份:2021
-
负责人:KENNETH Alan PERKINS
-
依托单位:
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
-
批准号:10620310
-
项目类别:
-
资助金额:$139.88万
-
财政年份:2021
-
负责人:KENNETH Alan PERKINS
-
依托单位:
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
-
批准号:10328576
-
项目类别:
-
资助金额:$200.73万
-
财政年份:2021
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Reinforcement-enhancing effects of NRT
-
批准号:9084517
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2014
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Threshold Dose for Nicotine Discrimination in Cigarettes
-
批准号:8573038
-
项目类别:
-
资助金额:$20.16万
-
财政年份:2013
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Threshold Dose for Nicotine Discrimination in Cigarettes
-
批准号:8720746
-
项目类别:
-
资助金额:$21.21万
-
财政年份:2013
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Reinforcement-enhancing effects of nicotine
-
批准号:8087136
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2011
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Reinforcement-enhancing effects of nicotine
-
批准号:8302290
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2011
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Behavioral Genetics of Mood-Induced Smoking
-
批准号:7761384
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2009
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Behavioral Genetics of Mood-Induced Smoking
-
批准号:7932226
-
项目类别:
-
资助金额:$23.56万
-
财政年份:2009
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Early Human Screening for Medication Efficacy
-
批准号:7612868
-
项目类别:
-
资助金额:$35.54万
-
财政年份:2009
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Tobacco Smoking, Nicotine and Negative Affect Relief
-
批准号:7038112
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2006
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Tobacco Smoking, Nicotine and Negative Affect Relief
-
批准号:7479671
-
项目类别:
-
资助金额:$21.2万
-
财政年份:2006
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Tobacco Smoking, Nicotine and Negative Affect Relief
-
批准号:7286751
-
项目类别:
-
资助金额:$21.63万
-
财政年份:2006
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Tobacco Smoking, Nicotine and Negative Affect Relief
-
批准号:7667715
-
项目类别:
-
资助金额:$21.2万
-
财政年份:2006
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Improved Human Screening of Cessation Medications
-
批准号:6864079
-
项目类别:
-
资助金额:$18.09万
-
财政年份:2004
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Affect, Context, and Placebo Responses to Nicotine
-
批准号:6584587
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2002
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Soc. for Research on Nicotine & Tobacco Annual Meeting
-
批准号:7071156
-
项目类别:
-
资助金额:$5.72万
-
财政年份:2002
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Soc. for Research on Nicotine & Tobacco Annual Meeting
-
批准号:6914144
-
项目类别:
-
资助金额:$5.86万
-
财政年份:2002
-
负责人:KENNETH Alan PERKINS
-
依托单位:
Affect, Context, and Placebo Responses to Nicotine
-
批准号:6913408
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2002
-
负责人:KENNETH Alan PERKINS
-
依托单位:
海外基金